Mycobacterium tuberculosis is a global health problem in part as a result of extensive cytotoxicity caused by the infection. Here, we show how M. tuberculosis causes caspase-1/NLRP3/gasdermin D-mediated pyroptosis of human monocytes and macrophages. A type VII secretion system (ESX-1) mediated, contact-induced plasma membrane damage response occurs during phagocytosis of bacteria. Alternatively, this can occur from the cytosolic side of the plasma membrane after phagosomal rupture in infected macrophages. This damage causes K+ efflux and activation of NLRP3-dependent IL-1β release and pyroptosis, facilitating the spread of bacteria to neighbouring cells. A dynamic interplay of pyroptosis with ESCRT-mediated plasma membrane repair also occurs. This dual plasma membrane damage seems to be a common mechanism for NLRP3 activators that function through lysosomal damage.
Mycobacterium tuberculosis (Mtb) is a human pathogen, causing about 1.6 million deaths per year1. A pathological hallmark of Mtb infection is extensive necrosis in infected tissues2. Necrosis has long been regarded as an unregulated type of cell death, but recently several programmed necrotic pathways have been identified3,4. A highly inflammatory form of programmed necrosis is pyroptosis, occurring mainly in myeloid cells after pattern-recognition receptor activation. In the classical pathway, activation of nucleotide-binding oligomerisation domain-like receptors (NLRs) or absent in myeloma 2 (AIM2)-like receptors (ALRs) by pathogen- or self-ligands drives the assembly of an inflammasome consisting of oligomerised NLRs or ALRs, the adaptor apoptosis-associated speck-like protein containing a CARD (ASC) and caspase-1 (refs. 5,6,7). Autocatalytic activation and cleavage of caspase-1 enables cleavage of pro-inflammatory cytokines interleukin (IL)-1β and IL-18, as well as the pore-forming molecule gasdermin D (GSDMD)8,9. IL-1β is released through GSDMD pores, and in larger amounts during pyroptosis, the lytic cell death that often follows GSDMD pore formation10,11,12,13.
IL-1β is a critical host-protective cytokine during Mtb infection, and canonical NLRP3 (NOD-, LRR- and pyrin-domain containing protein 3) and AIM2 inflammasome activation have been implicated in IL-1β release during Mtb infection in mouse and human macrophages14,15,16. However, NLRP3-independent routes to IL-1β release have been reported in mouse infection models, leaving the role for NLRP3 in vivo less clear17,18. The agonist of AIM2 is double-stranded DNA19,20,21, while the direct agonists of NLRP3 are not known. With few exceptions, two steps are required for NLRP3 activation: the priming signal involves increased expression of pro-IL-1β as well as inflammasome components such as NLRP3 itself, while the second signal is characterised by a range of cell damage events such as potassium (K+ ) and chloride (Cl–) efflux, mitochondrial dysfunction, metabolic changes, calcium fluxes, trans-Golgi disassembly and lysosomal damage7,22,23,24,25,26,27,28,29,30,31. K+ efflux in particular is considered a key determinant of NLRP3 activation for a range of triggers27, with some exceptions involving mitochondrial disruption and mitochondrial reactive oxygen species production, e.g. by the small-molecule compound Imiquimod28. Mitochondrial dysfunction seems closely tied to Mtb-induced necrosis as well32,33, but whether this is related to inflammasome activation is not clear. Inflammasome activation and pyroptosis by Mtb are dependent on the type VII secretion system 6-kDa early secretory antigenic target (ESAT-6) secretion system 1, ESX-1. ESX-1 secretes a range of protein substrates, and is postulated to mediate phagosome permeabilisation with full or partial translocation of Mtb into the cytosol34,35,36,37,38. Phagosomal permeabilisation presumably allows the release of Mtb DNA and activation of AIM2 (ref. 39), and release of active cathepsin B from damaged phagolysosomes has been proposed as a trigger for NLRP3 (refs. 23,40,41). However, off-target inhibitor effects and negative results in knockout mouse experiments have left the question open whether cathepsin release plays a role in NLRP3 inflammasome activation27,42,43,44.
Here, we use time-lapse- and correlative microscopy to spatiotemporally resolve Mtb-induced inflammasome activation and cell death at the single-cell level. Our findings identify a common mechanism where plasma membrane (PM) damage caused by Mtb or crystals triggers inflammasome activation, IL-1β release and pyroptosis, unless the membrane damage is balanced by repair mediated by the endosomal sorting complexes required for transport (ESCRT) machinery45.
Mtb induces canonical NLRP3 activation followed by pyroptosis
Based on previously published findings14,15,16,18,39, we hypothesised that Mtb induces the assembly of one of the ASC-dependent inflammasomes, NLRP3 or AIM2, upon infection of macrophages. THP-1 macrophages expressing ASC-GFP46 were infected with Mtb H37Rv constitutively expressing BFP (Mtb-BFP) and imaged after 24 h of infection or over an entire 24-h infection time course by time-lapse microscopy. The cell-impermeable DNA dye DRAQ7 was present in the medium to assess cell death. Mtb induced ASC-speck formation in infected macrophages (Fig. 1), and specks were exclusively localised to dead cells as indicated by DRAQ7-positive nuclei (Supplementary Fig. 1a). The number of dead cells, ASC specks and IL-1β secretion increased with increasing multiplicity of infection (MOI, Supplementary Fig. 1b). Treatment with the specific NLRP3 inhibitor MCC950 (ref. 47) or increased extracellular concentrations of KCl inhibited the formation of ASC specks, demonstrating that Mtb infection results in potassium efflux-driven activation of the NLRP3 inflammasome (Fig. 1a). Correspondingly, IL-1β secretion was inhibited by MCC950 and KCl, as well as the caspase inhibitors Z-VAD-FMK (pan-caspase) or VX765 (caspase-1). Treatment with Z-VAD, VX765, MCC950 or KCl all reduced cell death measured by DRAQ7 influx after 24 h, and DRAQ7 imaging results corresponded well to lactate dehydrogenase (LDH) cytotoxicity measurements in THP-1 cells (Supplementary Fig. 1c). Knocking down NLRP3 using CRISPR–Cas9 completely inhibited ASC-speck formation and reduced Mtb-induced cell death in a corresponding fraction of cells (Fig. 1b; Supplementary Fig. 1d). Similar results were observed with inhibitors and NLRP3 knockdown using the canonical NLRP3 activator LPS and nigericin (Supplementary Fig. 1e, f). Live-cell time-lapse microscopy of single Mtb-infected cells revealed nuclear DRAQ7 within few minutes after ASC-speck formation in pyroptotic cells, while DRAQ7 influx was absent for a period after ASC-speck formation in THP-1 cells deficient in GSDMD (Fig. 1c; Supplementary Fig. 1d), implicating cell lysis by GSDMD pores downstream of NLRP3 inflammasome activation by Mtb.
To address the physiological relevance of these findings, we measured cell death and IL-1β release in primary human monocytes and macrophages following 24-h infection with Mtb-BFP (Fig. 1d, e). Treatment with MCC950 or KCl abolished IL-1β release and significantly reduced cell death, implicating NLRP3-mediated inflammasome activation and pyroptosis also in primary human monocytes and macrophages. Caspase inhibitors were similarly effective in inhibiting IL-1β release, but less effective in inhibiting cell death in primary cells, as previously reported48,49.
Together, our data demonstrate that Mtb induces potassium efflux-driven activation of the canonical NLRP3 inflammasome upon infection of human monocytes and macrophages, followed by GSDMD-dependent pyroptotic cell death with release of IL-1β.
To gain a better understanding of the kinetics and prevalence of pyroptosis caused by Mtb, we imaged THP1-ASC-GFP cells infected with Mtb-BFP for 40 h by time-lapse microscopy. We noted the cumulative number of dead cells by pyroptosis, apoptosis and necrosis, scored as described in “Methods” and in Fig. 1f and the corresponding Supplementary Movies 1, 2 and 3. Pyroptosis was the dominating form of cell death during the first 24 h of infection. In line with this result, the necroptosis inhibitors Nec1s (receptor-interacting protein kinase 1 (RIPK1) inhibitor) and GSK’872 (RIPK3 inhibitor) did not affect cell death or ASC-speck formation in THP-1 cells (Supplementary Fig. 1g). However, in primary human monocytes and macrophages, there was also a contribution of RIPK3-mediated necroptosis 24 h post infection (Supplementary Fig. 1h, i). From time-lapse imaging, we observed that pyroptosis and necrosis primarily occurred in infected cells, while the proportion of apoptotic cell death was larger in uninfected bystander cells (Fig. 1f). In addition, the bacterial burden was higher in cells that formed ASC specks than in infected cells that did not (Fig. 1g). These results indicate that pyroptosis from Mtb infection is a cell-intrinsic effect, i.e. a direct result of infection within single cells.
We reasoned the relative reduction in pyroptosis, and the increase in necrosis 24–48 h of infection could be due to prolonged stimulation of Toll-like receptor (TLR) signalling, which has been reported to inhibit NLRP3 inflammasome activation50. Indeed, we observed that prolonged treatment (24 h) of THP-1 cells with TLR2 or TLR4 ligands prior to infection with Mtb decreased cell death and ASC speck formation to a similar extent as treatment with MCC950 (Supplementary Fig. 1j).
Pyroptosis causes severe damage and allows for spread of Mtb
Cell death is accompanied with morphological changes that can inform about the processes involved in execution of a particular cell death pathway. We investigated the ultrastructural features of pyroptosis using focused ion beam–scanning electron microscopy (FIB–SEM), allowing near-isotropic 3D resolution. Cells of interest were located by light microscopy using a correlation system we developed previously51. Uninfected THP1-ASC-GFP cells displayed a normal, healthy morphology (Fig. 2a). In comparison, infected, pyroptotic cells (i.e. with visible ASC specks) had severe ultrastructural disruptions, including fragmented and occasionally split nuclear membranes, large PM disruptions, organelle damage and leakage of content to the extracellular space (Fig. 2b). Mtb displayed a largely intact morphology, and some bacteria were observed in contact with the extracellular space, suggesting a means of escape from pyroptotic cells. Cells that were treated with LPS and nigericin and formed ASC specks displayed similar ultrastructural features as Mtb-infected pyroptotic cells, with nuclear and PM disruptions, cytosol leakage and organelle damage (Supplementary Fig. 2a).
To distinguish morphological changes that occurred as a consequence of pyroptosis from those that occurred prior to or during inflammasome activation, we infected cells for 5 h with Mtb-BFP in the presence of the caspase inhibitors Z-VAD and VX765. Cells were imaged live during infection with DRAQ7 in the medium, and chemically fixed within 2 min of the last captured frame. Cells with an ASC speck but without influx of DRAQ7 and no visible changes to cell morphology were chosen for further imaging by FIB–SEM. The morphology was similar to uninfected cells, with intact organelles, a continuous PM and a double nuclear membrane (Fig. 2c). Similar results were observed in THP-1 GSDMD KD cells (Supplementary Fig. 2b). Hence, the dramatic morphological changes in pyroptotic cells are a consequence of the pyroptotic cell death process itself.
Next, we investigated the structure of the ASC speck using the correlative imaging approach. ASC specks were visible in SEM images as aggregates with a branched structure and a size of about 1–2.5 µm in THP1-ASC-GFP cells, both when infected with Mtb and when treated with LPS and nigericin (Fig. 2d, e). The structure corresponds well to that previously observed in a zebrafish model52. The speck in the living (Z-VAD + VX765-treated) cell was located in an open space in the cytosol of the cell, seemingly devoid of other organelles. To ensure that the ASC-speck structure was not a consequence of ASC overexpression or tagging, we treated primary human monocytes with LPS and nigericin, and visualised active caspase-1 by FAM-YVAD-FMK (FLICA). Caspase-1 is stabilised in its active form on the inflammasome53, and we therefore hypothesised that the point with the highest fluorescence intensity from FLICA treatment would be the point where the speck was assembled. Indeed, by correlative light and EM (CLEM), we identified a similar branched structure in LPS and nigericin-treated primary human monocytes, albeit with a smaller size than that observed in THP-1 cells (~0.8 µm). Our data demonstrate that ASC specks also form in primary cells, without tagging or overexpression of selected proteins.
To elaborate on the possible consequences of pyroptosis on Mtb spreading, we investigated pyroptosis during time-lapse imaging. On average, ~25% of Mtb bacilli were lost into the medium immediately after pyroptosis (Fig. 2f), while the rest were trapped in the pyroptotic cell. However, Mtb that was trapped in pyroptotic cells was phagocytosed by neighbouring cells. Further, this induced ASC-speck formation with pyroptosis in the new host cell, thus propagating inflammasome activation and cell death (Fig. 2g; Supplementary Movie 4). This indicates that pyroptosis enables some bacteria to spread immediately after cell death, and that bacteria that are trapped in the ghost cell can also contribute to further local spread of infection by efferocytosis.
Mitochondrial depolarisation accompanies pyroptosis
It has been reported that Mtb lacking the region of difference 1 (MtbΔRD1), where most ESX-1-related genes are located, is deficient in inflammasome activation14,15,18. Our results are in line with these reports, as MtbΔRD1 caused significantly less ASC-speck formation and cell death of THP-1 cells than wild-type Mtb (Fig. 3a). We also observed that Mtb grown in the absence of the detergent tween-80 is more potent in inflammasome activation than Mtb grown in the presence of tween (our regular growth condition). Detergent is found by others to perturb the mycobacterial capsule, in particular decreasing the abundance of ESX-1-related proteins on the Mtb surface/capsule54,55. Our data thus show that inflammasome activation correlates with ESX-1 activity and the integrity of the Mtb capsule, suggesting that deposition of ESX-1-related factors on the Mtb surface/capsule is important for Mtb inflammasome activation.
Tuberculosis-necrotising toxin (TNT, the C-terminal end of the channel protein with necrosis-inducing toxin (CpnT)) is secreted from Mtb and released into the host cell cytosol in an ESX-1-dependent manner, leading to macrophage necroptosis33,56,57. We therefore wanted to investigate if TNT contributes to the ESX-1-dependent inflammasome activation. To this end, we infected THP-1-ASC-GFP macrophages with wild-type Mtb, MtbΔcpnT or MtbΔcpnT complemented with cpnT containing either the catalytically active or inactive form of TNT (MtbΔcpnT::cpnT and MtbΔcpnT::cpnT*, respectively). We found that all Mtb mutants and complemented strains were similarly competent in inflammasome activation, and that treatment with MCC950 had a similar effect across bacterial strains in inhibiting ASC speck formation (Fig. 3b; Supplementary Fig. 3a). This indicates that TNT does not play a role in Mtb-induced inflammasome activation in our system.
Finally, we assessed the possible involvement of mitochondrial membrane perturbation prior to inflammasome activation and pyroptosis, an event that could also be linked to the activity of ESX-1 and related proteins. Mitochondrial damage has been strongly implicated in inflammasome activation in general, and in Mtb-induced necrosis24,28,32,33,58,59. In particular, infection with Mtb H37Rv was reported to cause a loss in mitochondrial membrane potential (ΔΨm), which was inhibited by cyclosporine A (CsA), a cyclophilin D inhibitor that prevents formation of the mitochondrial permeability transition pore33,60. However, we did not see an effect of CsA on Mtb-induced inflammasome activation and pyroptosis after 24 h of infection (Fig. 3c). In addition, we monitored the ΔΨm by live-cell imaging of cells infected with Mtb-BFP and labelled with tetramethylrhodamine ethyl ester (TMRE), a dye that is accumulated in the mitochondria in proportion to ΔΨm (ref. 61). We observed that ΔΨm was stable in infected cells until ASC-speck formation, and that the potential quickly dropped after ASC-speck formation as measured by a drop in TMRE intensity (Fig. 3d; Supplementary Movie 5). This immediate drop in TMRE intensity after ASC-speck formation was abolished in THP-1 GSDMD KD macrophages, without any adverse effects on the ability of the cells to form ASC specks, suggesting that GSDMD activity and possibly PM disruption during cell death are required for mitochondrial destabilisation (Fig. 3e; Supplementary Movie 6). Similar results were obtained with LPS and nigericin treatment, where ΔΨm dropped only after ASC-speck formation, and the drop was inhibited in GSDMD KD cells (Supplementary Fig. 3b and Supplementary Movies 7 and 8). We conclude that gross mitochondrial membrane disruption is not a prerequisite for inflammasome activation caused by Mtb or LPS and nigericin, but rather accompanies pyroptosis. These results are also consistent with the intact mitochondrial morphology observed by EM in living cells with an assembled inflammasome (Fig. 2c).
Phagosomal damage is a prerequisite for NLRP3 activation
One of the main effects of the ESX-1 secretion system is destabilisation of phagosomal membranes35,36,37. We therefore asked how phagosomal rupture is related to inflammasome activation and pyroptosis. Galectin-3 (Gal-3) binds to exposed glycosylated proteins usually confined to the inner phagosomal membrane, and has been used as a marker for ruptured phagosomes62. We infected THP1-Gal-3-mScarlet macrophages and observed that Gal-3 was indeed recruited to the vicinity of wild-type Mtb, but not to the vicinity of MtbΔRD1 (Fig. 4a), and Gal-3 recruitment was enhanced upon infection with Mtb grown in the absence of tween (Fig. 4b). Gal-3 recruitment to ruptured Mtb phagosomes occurred prior to inflammasome activation in about 80% of pyroptotic cells, and a typical sequence of events is depicted in Fig. 4c and Supplementary Movie 9.
Using CLEM, we confirmed that Gal-3 accumulation corresponds to cytosolic contact of Mtb (Fig. 4d). Mtb in phagosomes devoid of Gal-3 were surrounded by a tightly apposed and continuous phagosomal membrane, in contrast to bacteria associated with Gal-3 that had no visible phagosomal membrane, and were in direct contact with the host cell cytosol (Fig. 4d, e). Furthermore, the CLEM approach revealed in great detail the presence of clusters of vesicles and membranous structures only in regions where Gal-3 was recruited close to Mtb. The ultrastructure of Gal-3-positive compartments is similar to that previously observed for Mtb residing in LC3+ compartments in lymphatic endothelial cells63. We therefore investigated the recruitment of LC3B in relation to Gal-3 by live-cell imaging of Mtb-BFP-infected THP-1 macrophages expressing mNeonGreen-LC3B and Gal-3-mScarlet. Indeed, we observed recruitment of LC3B around intracellular Mtb shortly after recruitment of Gal-3 in 98% of events (Fig. 4f, g; Supplementary Movie 10), suggesting that ruptured Mtb phagosomes are targeted by autophagy64,65,66. To investigate if autophagic targeting of Mtb leads to formation of mature, acidified autophagosomes, THP-1 macrophages expressing Gal-3-mScarlet were labelled with LysoView633 (Supplementary Fig. 4a). Only ~20% of Mtb in ruptured phagosomes was later found in acidified compartments. Together with the observation by FIB–SEM that Mtb associated with Gal-3 phagosomes retained cytosolic contact, these results suggest that autophagosomal sequestration of Mtb after phagosomal rupture is inefficient (Supplementary Fig. 4b).
Mtb inflammasome activation is independent of pH and cathepsins
The ability to disrupt phagosomes seems important for inflammasome activation by Mtb, and it has been reported that phagosomal acidification is a prerequisite for the membrane-damaging activity of ESX-1 (refs. 67,68,69). In addition, active cathepsin release from ruptured phagolysosomes has been suggested as a trigger of NLRP3 inflammasome activation23,40,41. We therefore went on to investigate the possible involvement of phagosomal acidification and release of active cathepsins in inflammasome activation and pyroptosis by Mtb. Live-cell imaging of THP1-Gal-3-mScarlet or THP1-ASC-GFP cells in the presence of the pH-sensitive dye LysoView633 revealed that Mtb was equally efficient at escaping from acidified and neutral compartments (Fig. 5a–c; Supplementary Movies 11 and 12), suggesting that phagosomal acidification is not a prerequisite for Mtb escape into the cytosol. The LysoView signal in single cells was stable prior to ASC-speck formation, indicating that there is no general disruption or degradation of acidified lysosomes prior to inflammasome activation (Fig. 5d, e; Supplementary Movie 13). In addition, we did not see any effect on cell death or ASC-speck formation when cells were treated with Bafilomycin A1 (BafA1) which inhibits lysosomal acidification by V-ATPase, or the pan-cathepsin inhibitor K777, during infection (Fig. 5f), despite efficient cathepsin B inhibition (Supplementary Fig. 5). Compared with K777, cathepsin B inhibitor Ca-074-Me was less potent and had clear off-target effects on inflammasome activation during LPS and nigericin treatment (Supplementary Fig. 5). These results demonstrate that Mtb causes inflammasome activation and pyroptosis independently of phagolysosomal acidification and release of active cathepsins.
Mtb ESX-1 directly damages the host cell plasma membrane
K+ efflux precedes NLRP3 activation for a range of known triggers27. Common for many of those triggers is that they permeabilise the PM to K+, e.g. by opening a membrane-resident pore (P2X7, pannexin-1) or by inserting and making new pores (Mixed Lineage Kinase-domain Like protein (MLKL), complement, bacterial pore-forming toxins)70. We and others have shown that Mtb-induced NLRP3 inflammasome activation is dependent on K+ efflux, and it has also been shown that Mtb ESX-1 can be haemolytic71. Moreover, PM damage has been observed during Mtb infection, and PM repair protects macrophages from necrotic cell death72. However, whether Mtb could directly cause PM damage or if PM damage is a consequence of Mtb-induced intrinsic cell death pathways, was not addressed. To monitor PM integrity, we made THP-1 reporter cell lines with an mNeonGreen fluorescent protein tag on the Ca2+-binding protein Apoptosis-Linked Gene 2 (ALG-2), which is recruited to sites of PM damage by calcium influx73,74,75. We imaged Mtb-BFP-infected THP-1 macrophages by time-lapse confocal microscopy and observed ALG-2 recruitment in infected cells, almost 90% of which occurred in close vicinity to Mtb bacteria (Fig. 6a, b; Supplementary Movies 14 and 15). Mtb infection also caused ALG-2 recruitment close to Mtb in primary human macrophages (Supplementary Fig. 6a). We observed ALG-2 recruitment near Mtb both without prior Gal-3 recruitment and subsequent to Gal-3 recruitment around Mtb, with a distribution close to 50/50 between the two categories (Fig. 6b). This result suggests that Mtb damages the host cell PM either during phagocytosis or following phagocytosis and phagosome rupture.
As damage to the PM from the cytosolic side by already-internalised bacteria has not been described before, we examined whether ALG-2 recruitment next to Gal-3+ Mtb compartments indeed occurred at the PM. Total internal reflection fluorescence (TIRF) microscopy is only sensitive to the region within ~100 nm from the substrate, meaning it specifically detects events occurring at the PM76. We imaged infected THP-1 macrophages with wide-field and TIRF microscopy simultaneously (Fig. 6c; Supplementary Movie 16). Since the TIRF microscope is outside the BSL3 facility, we used an Mtb auxotroph strain with intact ESX-1 function (Mtb mc26206). From wide-field imaging, we observed Gal-3 recruitment to intracellular Mtb phagosomes that were out of range for TIRF, while ALG-2 recruitment was observed in TIRF and wide-field modes when Mtb came into the range of the TIRF excitation, demonstrating that ALG-2 recruitment following Gal-3 also occurs at the PM.
To better understand the extent of PM damage marked by ALG-2 events, we imaged cytosolic calcium levels using the fluorescent indicator Calbryte-590 during time-lapse microscopy of Mtb-infected THP-1 cells. We observed a consistent influx of calcium when ALG-2 was recruited (Fig. 6d, e; Supplementary Movie 17), which is expected considering that ALG-2 is known to be recruited by calcium influx73,74,75. Calcium influx was not observed when Gal-3 was recruited to Mtb phagosomes (Fig. 6e; Supplementary Fig. 6b and Supplementary Movie 18). We also imaged infected THP-1 macrophages with the membrane-impermeable RNA/DNA dye propidium iodide (PI) present in the medium. We noted a consistent local influx of PI in regions of Mtb-localised ALG-2 recruitment events, in contrast to control cells with no apparent ALG-2 events (Fig. 6f, g; Supplementary Movie 19). Taken together, these data demonstrate that Mtb damages the macrophage PM when the bacteria are in close proximity. The damage caused by Mtb makes the PM permeable to both ions (Ca2+ and K+) and larger molecules such as PI.
To investigate the ultrastructure of Mtb-associated PM damage, we performed live-cell CLEM. After live-cell imaging and rapid fixation, recent ALG-2 recruitment events were imaged by confocal or Airyscan microscopy, and further by FIB–SEM tomography (Fig. 6h; Supplementary Fig. 6c). At the location of fluorescent ALG-2 signal and directly adjacent to Mtb, multiple 50–100-nm-sized vesicles were visible, indicative of ESCRT-mediated PM repair74,77.
Plasma membrane damage activates the NLRP3 inflammasome
Based on the dependency of NLRP3 activation on K+ efflux as shown by us and others27, we hypothesised that the ability of Mtb to cause PM damage and its subsequent permeabilisation to ions would be linked to inflammasome activation. We therefore imaged THP-1-ALG-2-mNeonGreen/Gal-3-mScarlet/ASC-mIRFP670 macrophages by time-lapse microscopy during infection with Mtb-BFP. An example time course is shown in Fig. 7a and Supplementary Movie 20. We recorded the time points of all Gal-3 (phagosomal rupture) and ALG-2 (PM damage) recruitment events in cells later forming ASC specks, along with the time point of ASC-speck formation. PM damage preceded ASC-speck formation in 87% of cells infected with Mtb and occurred closer in time to ASC-speck formation than Gal-3 recruitment to Mtb phagosomes (Fig. 7b). While the median time from phagosomal rupture to ASC speck formation was 2 h, the median time from PM damage to ASC-speck formation was 1 h. Moreover, within 20 min before ASC-speck formation, 48% of cells had ALG-2 events and 23% of cells had Gal-3 events, compared with 1% and 4%, respectively, in infected control cells over an average 20-min period (Fig. 7c). Thus, especially PM damage events occur much more frequently before ASC specks form, connecting these events at the single-cell level. When cells were infected with MtbΔRD1, which does not damage host cell membranes, we did not observe any ALG-2 recruitment, and ASC speck formation was significantly reduced, as noted earlier (Fig. 3a). Treatment with the phagocytosis inhibitor cytochalasin D during infection with Mtb only partially inhibited ASC-speck formation after 24 h, despite strong inhibition of Mtb uptake, supporting the conclusion that Mtb also can activate the NLRP3 inflammasome through PM damage from outside of the cell (Fig. 7d; Supplementary Fig. 7a). Furthermore, when inflammasome activation was inhibited by MCC950 or extracellular KCl during infection, the number of ALG-2 events per cell remained constant while ASC-speck formation was inhibited, confirming that PM damage happens prior to NLRP3 inflammasome activation (and is not caused e.g. by active GSDMD) (Fig. 7e; Supplementary Fig. 7b).
ALG-2 and the ALG-2-interacting protein X (ALIX) are early components of ESCRT-mediated PM repair73,74. We went on to inhibit PM repair by knocking down ALG-2 or ALIX by CRISPR–Cas9 in THP-1 macrophages. Mtb caused significantly more inflammasome activation and pyroptosis both in ALG-2 and ALIX KD macrophages after 24 h of infection, compared with control cells (Fig. 7f; Supplementary Fig. 7c). Together, these results demonstrate that Mtb-induced PM damage is a trigger of NLRP3 inflammasome activation in macrophages, and that PM repair mechanisms suppress inflammasome activation and pyroptosis caused by Mtb.
Silica crystals cause silicosis, a disease with severe lung pathology, and a known risk factor for tuberculosis23,78. Silica activates the NLRP3 inflammasome, which has been associated with phagolysosomal damage23. We decided to test if PM damage is involved in triggering NLRP3 activation by silica crystals in a similar manner as with Mtb. TIRF and wide-field microscopy of THP-1 macrophages revealed Gal-3 recruitment to intracellular silica crystals and ALG-2 recruitment to sites at the PM (Fig. 8a; Supplementary Movie 21), indicating that silica crystals are also capable of disrupting phagosomal membranes and the PM. A typical time course of events culminating in ASC speck formation is shown in Fig. 8b and Supplementary Movie 22. PM damage preceded ASC-speck formation after silica stimulation in most cells (90%). Further, silica-induced ALG-2 events were closer in time to ASC specks than Gal-3 events, similar to what we observed during Mtb infection (Fig. 8c). In total, 71% of cells that assembled ASC specks had an ALG-2 recruitment event within the last 20 min before ASC speck formation, while ~25% of the cells had a Gal-3 recruitment event within the same period (Fig. 8d). Nigericin, which directly depletes the cell of K+ as a K+ ionophore, or imiquimod, which is an NLRP3 trigger acting independently of K+ efflux28, did not result in any visible Gal-3 or ALG-2 recruitment events prior to inflammasome activation (Supplementary Fig. 7d, e and Supplementary Movies 23 and 24).
Further, we investigated if direct damage to lysosomes without PM damage could activate NLRP3. For this purpose, we used the lysosome-targeted photosensitiser TPCS2a79 (Supplementary Fig. 7f, g and Supplementary Movie 25). However, despite loss of lysosomal pH and Gal-3 recruitment indicating lysosomal damage after blue-light excitation in the presence of TPCS2a, we did not observe ALG-2 events at the PM or ASC-speck formation. These data show that PM damage (with subsequent K+ efflux) is a central event upstream of NLRP3 inflammasome activation by Mtb and silica, and that lysosomal damage itself is not sufficient to activate NLRP3.
Both AIM2 and NLRP3 have been implicated in IL-1β release during Mtb infection of macrophages14,15,16,39, while the occurrence of pyroptosis as a distinct route of cell death has been less clear15,48,49,80. Here we establish that ESX-1-mediated PM damage causes K+ efflux, NLRP3 activation and subsequent caspase-1-mediated IL-1β release in THP-1 cells and human primary monocytes and macrophages. We also demonstrate at the single-cell level that NLRP3 activation causes rapid pyroptosis through caspase-1 and GSDMD in THP-1 cells. We emphasise that pyroptosis is an all-or-nothing response after ASC-speck formation, consistent with previous reports81. In primary human monocytes and macrophages, NLRP3 inhibitors reduced cell death, although the dependence on caspase-1 was less clear for macrophages. It has previously been reported that monocytes require less stimulation than macrophages to activate an NLRP3-mediated inflammatory response82, and PMA differentiation of THP-1 cells upregulates pro-inflammatory cytokines and NLRP3 pathway components, thus potentially making them more prone to activation of this pathway83. In a recent report, even in response to the canonical NLRP3 trigger LPS and nigericin, a low proportion (<5%) of human macrophages formed ASC specks, ascribed to a regulatory role of alternative NLRP3 isoforms84. Accordingly, the poorer inhibition of pyroptosis in macrophages than in monocytes/THP-1s is likely due to a lower frequency of macrophages responding with inflammasome activation and IL-1β release84, which are the cells prone to undergo pyroptosis.
Furthermore, caspase inhibitors have differing efficacies in preventing pyroptosis, despite potent inhibition of IL-1β release85, and there is also crosstalk between cell death pathways and caspase redundancy during inflammasome activation86,87,88,89. Together with long time courses of infection, these factors could contribute to why caspase-1 inhibitors are less efficient than NLRP3 inhibition in preventing primary cell death, which is consistent with previous reports of caspase-independent cell death during Mtb infection48,49.
We show at the single-cell level that a high bacterial burden is linked to NLRP3 activation, and other groups have also shown the correlation between bacterial burden and cell death49,90,91. One could hypothesise that pyroptosis would occur in vivo in tissue regions where Mtb replication results in high bacterial loads, such as in necrotising granulomas during active phases of the disease when Mtb needs to spread91. Further, although IL-1β is a central cytokine in a successful immune response against tuberculosis92, a gain-of-function mutation in NLRP3 has been associated with poor clinical outcome in tuberculosis patients93. Thus, further studies in relevant in vivo systems will be necessary to clarify the prevalence and importance of NLRP3 activation and the pyroptotic pathway during different stages of tuberculosis disease.
Necroptosis is another necrotic cell death pathway induced by Mtb, mainly caused by the secreted NAD+ glycohydrolase TNT32,33. In some cases, there is crosstalk between necroptosis and NLRP3 activation and pyroptosis94,95, but our results indicate that these are distinct processes during Mtb infection. We do not see an effect of necroptosis inhibitors or TNT-deficient mutants in THP-1 cells on NLRP3 activation, while in primary human monocytes and macrophages, cell death was reduced by RIPK3 inhibition, suggesting that both pathways are indeed activated in more physiological systems. The discrepancy between our results and those of Pajuelo et al.33 with regard to cell death by TNT and necroptosis inhibitors in THP-1 cells is likely due to the longer infection time used by Pajuelo and colleagues: our analyses are mostly performed after 24 h of infection where pyroptosis is most prominent, but we also see an increase in necrotic cell death at later time points. Mitochondrial damage and depolarisation have been linked to necrosis during Mtb infection, both necroptosis and other forms of necrosis32,33,59. By time-lapse imaging, we show that destabilisation of mitochondria accompanies pyroptosis rather than causing inflammasome activation in the NLRP3 pathway. In summary, our results highlight that Mtb-induced pyroptosis is an independent pathway distinct from other programmed necrotic pathways such as necroptosis, although both pathways and others can and likely do occur during Mtb infection in vivo. Which pathway is triggered first is likely determined both by the state of the host cell (e.g. activation state, immune environment or previous stimulation) and the nature of the damage by Mtb, where more severe damage causes K+ efflux and pyroptosis, while lesser damage could allow, e.g. TNT secretion and subsequent activation of necroptosis.
The precise mechanism of NLRP3 activation has evaded the community for over a decade. Although alternative routes were proposed, inhibition of NLRP3 activation by high concentrations of extracellular KCl positions K+ efflux as the predominant upstream effector of NLRP3 activation. This is also the case for Mtb, as we and others have shown40,96. The similarities in ASC-speck structure and progression of pyroptosis after NLRP3 activation by Mtb infection or nigericin, which is a K+ /H+ ionophore, suggest that differences are linked to the mechanism of K+ efflux. Lysosomal damaging agents are one of the most clinically relevant classes of NLRP3 triggers97. Cathepsin release from damaged lysosomes, especially of Cathepsin B, is one commonly proposed connection, although how this further causes K+ efflux has been unclear23,40,41. A main source of this confusion is the widespread use of the Cathepsin B inhibitor Ca-074-Me, which appears to inhibit NLRP3 activation independent of Cathepsin B inhibition27,42,43,44 (Supplementary Fig. 5). We show that although Mtb can damage acidified phagolysosomes, this is not required for NLRP3 activation, and there is no general loss of lysosomal content prior to NLRP3 inflammasome activation. Instead, PM damage appears to be the key event to trigger NLRP3 during Mtb infection. Also, in response to silica crystals, a canonical lysosome-damaging NLRP3 trigger, we observe PM damage prior to NLRP3 activation. PM permeabilisation can cause ion fluxes down their electrochemical gradients and thus activate NLRP3 by K+ efflux70.
PM damage during phagocytosis of Mtb and silica explains some of the NLRP3 activation events, but our imaging data show that PM damage can also occur from the cytosolic side after uptake, if Mtb or silica damage the phagosome and subsequently come into contact with the PM. This mechanism explains how something that primarily disrupts phagolysosomes can cause K+ efflux and NLRP3 activation. Strikingly, localised and controlled lysosomal damage caused by a lysosomal photosensitiser will not subsequently damage the PM and did not cause NLRP3 activation. Since PM damage is actively repaired through many routes, including the Ca2+ -dependent ESCRT machinery45,73,74,75, it is also interesting to note that this branch of ESCRT emerges as a suppressor of NLRP3 activation and cell death during Mtb infection. The ESCRT machinery was also recently shown to be involved in repair of phagosomes damaged by mycobacteria98,99, and to regulate pyroptosis or necroptosis by repairing GSDMD100 or MLKL pores101, respectively. These observations further underline the importance of the ESCRT machinery in regulating inflammation and maintaining cell viability.
How ESX-1 damages membranes is not well understood. Several papers indicate a central role for the secreted protein ESAT-6, acting through membrane lysis or membrane pore formation34,67,69,102,103. However, this has recently been attributed to detergent contamination, and a contact-induced form of gross membrane disruption caused by undefined ESX-1 activity has been proposed71. ESX-1-secreted substrates are also retained in the mycobacterial capsule, and ESAT-6 has been observed to quickly disappear upon contact between bacteria and host macrophages54,55. Our results also indicate a contact-induced damage, as damage events are localised to contact points between Mtb and the PM. The damage upon contact could be caused by ESX-1-dependent factors in the bacterial capsule or other factors that are diminished by the presence of the detergent tween, as Mtb cultured without tween showed increased membrane-damaging activity and higher inflammasome activation and cell death. The damage also appears to be severe, as shown by ultrastructural investigations, the simultaneous recruitment of Gal-3 and loss of lysosomal pH in phagolysosomes and the simultaneous recruitment of ALG-2 and PI and calcium influx during PM damage. Furthermore, the membrane-damaging activity of ESX-1 is unique in that it can act from both sides of the PM. Our ultrastructural investigations of sites of PM damage close to Mtb indicate that the PM repair response in the affected cell is quickly initiated, complicating a direct observation of the initial damage.
Mtb needs to escape from host macrophages to efficiently replicate and spread to new hosts. Based on our data, we propose a model where preservation of membrane integrity is key to contain Mtb infections. The ESCRT machinery repairs damages caused by Mtb to the PM and phagosomes, whereas autophagy sequesters ruptured Mtb phagosomes. Inefficient countermeasures by the host cell allow for K+ efflux and NLRP3 inflammasome activation, in which case pyroptosis is inevitable and facilitates the spread of Mtb to neighbouring cells and eventually to new hosts. As shown here and elsewhere32,33,59,104, multiple forms of programmed necrotic pathways, including pyroptosis, necroptosis and others occur during Mtb infection. Mtb likely exploits these multiple pathways simultaneously to spread within a host. Cell necrosis pathways, including pyroptosis, are thus attractive as possible targets for host-directed therapeutic strategies by limiting both bacterial spread and excessive inflammation105.
We also show that PM damage rather than phagolysosomal damage is a shared mechanism with the crystalline NLRP3 trigger silica. Crystalline triggers cause NLRP3-driven sterile inflammatory diseases in the lungs and the cardiovascular system97. In particular, silicosis is a known risk factor for tuberculosis, and studies have shown both increased phagocytosis and impaired macrophage function upon co-exposure to silica and Mtb78. Due to the similar progression of phagosomal and PM damage during Mtb and silica exposure, we hypothesise that these processes could be exacerbated during simultaneous exposure, driving pathology. Overall, our findings point to PM damage as a shared mechanism for this group of NLRP3 activators, extending the relevance beyond tuberculosis disease.
All reagents used in this paper are listed in Supplementary Table 1.
THP-1 cells (ATCC Cat#TIB-202, ASC-GFP from Prof. Emad Alnemri) were maintained in RPMI 1640 supplemented with l-glutamine, 10 mM HEPES and 10% FCS, and passaged regularly to keep the cell density between 0.2 and 1 × 106/mL. Cell lines were routinely tested for mycoplasma. Human peripheral blood mononuclear cells (PBMCs) were isolated with Lymphoprep from buffy coats obtained from healthy volunteers (both male and female) at the blood bank of St. Olav’s Hospital (Trondheim, Norway), or directly from the blood of healthy volunteers (both male and female) after informed consent. Collection of human blood was approved by the Regional Committee for Medical and Health Research Ethics in Central Norway.
Mtb strains were grown at 37 °C in Middlebrook 7H9 medium supplemented with 0.2% glycerol, 0.05% Tween-80 and oleic acid, albumin, dextrose and catalase (OADC). For Mtb mc26206 auxotroph strain, 50 µg/mL l-leucine and 24 µg/mL d-pantothenate were added to the growth medium. Mtb bacteria were grown in the absence of Tween-80 for 24 h prior to infection in experiments where no-tween growth conditions are indicated.
Lentiviral production was performed in HEK293T cells using 3rd generation packaging system with pMDL.g/pRRE, pMD2.G and pRSV-Rev and JetPrime (PolyPlus) as transfection reagents according to the manufacturer’s instructions106. Virus-containing supernatant was harvested 2 and 3 days post transfection, and filtered through 0.45-µm PES membrane filters. THP-1 cells were transduced in the supernatant by 90 min of spinoculation at 32 °C, 1000 g in the presence of 8 µg/mL polybrene, and selected in 1 µg/mL puromycin, 10 µg/mL blasticidine or 100 µg/mL hygromycin for 1 week. Finally, the cells were selected for a consistent moderate expression level of fluorescent constructs by 1–2 rounds of FACS (BD Aria II). CRISPR-modified THP-1 cells were used directly as a polyclonal population after puromycin selection. Mtb H37Rv, Mtb H37RvΔRD1 and Mtb mc26206 were transformed with msp12::EBFP2 and selected on hygromycin (65 µg/mL) 7H10 plates (Difco/Becton Dickinson).
Generation of new vectors
Gateway cloning was used to generate lentiviral expression vectors. Human Galectin-3, human ALG-2 (THP-1 cDNA), human ASC, human LC3B (synthetic GeneArt Strings, ThermoFisher), mScarlet (synthetic), mRuby3, mNeonGreen, mIRFP670 and SNAPf tag were PCR-amplified and cloned into Gateway pEntry vectors. All pEntry constructs were verified by Sanger sequencing (GATC Biotech) before further use. PuroR in pLex307 was replaced with BlastR or HygR to generate Gateway lentiviral destination vectors with the corresponding antibiotic resistances. Two-fragment Gateway recombination with pLex307, pLex307-Blast or pLex307-Hyg was performed to generate ASC-mNeonGreen, ASC-mIRFP670, Galectin-3-mScarlet, Galectin-3-SNAP, mNeonGreen-LC3B and mNeonGreen-ALG-2 constructs. Guide RNAs targeting GSDMD, NLRP3, ALG-2 or ALIX were cloned into LentiCrispr v2 by BsmBI digestion and ligation.
Verification of CRISPR knockdown
Knockdown in the cell pool was verified by cleavage assay (GeneArt genomic cleavage assay, ThermoFisher), sequencing and TIDE analysis107 and/or western blotting. Uncropped and unprocessed western blot scans are available in the Source Data File. Antibodies and dilutions for western blot were NLRP3 (1:1000), GSDMD (1:1000), ALG-2 (1:500) and ALIX (1:1000).
Macrophage and monocyte infection and stimulation
Before use, THP-1 cells were differentiated at a concentration of 300.000 cells/mL in medium containing 100 ng/mL phorbol 12-myristate 13-acetate (PMA) for 3 days, washed in cell medium and rested 1 day prior to experiments. Primary human monocytes were selected by plastic adherence of PBMCs for 1 h, followed by 3× washing in HBSS, and cultured in RPMI with 10% A+ serum (blood bank of St Olavs Hospital, Trondheim, Norway). For primary macrophage experiments, primary monocytes were selected by α-CD14 bead isolation (Miltenyi Biotech) and seeded out in RPMI with 5% A+ serum and 50 ng/ml rhGM-CSF (Peprotech, Gibco–ThermoFisher) for 3 days. At the third day, the media was replaced with normal cell medium with 5% A+ serum.
Mtb bacteria were grown until OD600 was 0.4–0.55 (log phase), then pelleted at 2400 g for 10 min, resuspended in RPMI with 10% A + serum to opsonise bacteria prior to infection and sonicated 2–3 times for 5 s at 70% power (Branson Digital Sonifier, S-450D). Clumped bacteria were removed by centrifuging at 300 g for 4 min. The supernatant containing bacteria was diluted in RPMI with 10% human A+ serum to MOI 20, unless otherwise indicated, assuming 1 OD600 = 3 × 108 bacteria/mL. For primary human macrophage experiments, the second centrifugation was done at 200 g for 1 min, and bacteria were resuspended in 5% A+ serum (to reduce the background of the LDH readout). Bacteria were applied to cells for 45 min (THP-1 and monocytes) or 4 h (primary human macrophages) with or without inhibitors, followed by washing in HBSS and replacement of the media to normal cell medium with 10% or 5% A+ serum with or without inhibitors, or Leibovitz L-15 CO2-independent medium with 10% A+ serum for live-cell imaging. The typical condition of MOI 20 infection gave ~50% infection rate with 1–20 bacteria per macrophage. Inhibitor concentrations were DMSO control (1:400), z-VAD-FMK (50 µM for THP-1 cells, 20 µM for primary human cells), VX765 (50 µM), MCC950 (10 µM), KCl (40 mM), Nec1s (10 µM), GSK-872 (5 µM), Cyclosporin A (5 µM), K777 (15 µM) or Bafilomycin A1 (50 nM). Supernatants were harvested for ELISA or LDH assays after 24 h, and analysed by human IL-1β kit or LDH cytotoxicity kit according to the manufacturer’s instructions.
In stimulation experiments, the following conditions were used: LPS (10 ng/ml LPS, 3 h), FSL-1 (10 ng/ml), Pam3Cys4K (10 ng/ml), nigericin (10 µM, 1 h, unless otherwise stated), imiquimod (20 µg/ml, 1 h) and silica (100–200 µg/ml). When used in combination, inhibitors were added 30 min before and were present during stimulation.
THP-1 cells were seeded in 35-mm glass-bottom dishes (Ibidi) or 96-well glass-bottom plates (Cellvis) as above. For some experiments, bacteria were added at a lower MOI and not washed to be able to follow the entire course of infection. Cells were imaged on a Leica SP8 confocal microscope with a 37 °C incubator using a 40 × 1.3 or 20 × 0.75 oil immersion objective or 10 × 0.4 air objective at the time points indicated in the paper. TIRF/wide-field imaging was done on a Zeiss Laser TIRF 3, with a 63 × 1.46 oil objective and Hamamatsu EMX2 EMCCD camera. For quantification of cell death (by DRAQ7 signal) and ASC specks at defined time points with and without inhibitors or knockdown, 16 fields of view containing n > 2000 cells in total were imaged per condition in triplicate. For time-lapse imaging by confocal microscopy, typically six fields of view comprising >500 cells in total were imaged at 30–45-s intervals, while TIRF/WF was done on one to four fields of view comprising 10–40 cells at 10–30-s intervals. Fields of view were defined based on plate coordinates, without bias from observation of the sample, and all cells or events within every captured field of view were included in the analysis. For some experiments, DRAQ7 (0.15 µM), TMRE (10 nM), LysoView633 (1:10 000) or Calbryte-590 (5 µM) was preincubated for 30–60 min and added to the cell medium during Mtb infection. Calbryte-590 was only preincubated and not re-added. In cells with SNAP tag, cells were labelled with 1:200 SNAP-Cell 647-SiR for 15 min, washed 3× in cell medium and rested for 30 min before use. For lysosomal damage by photosensitiser, TPCS2a was added to the medium (0.4 µg/mL) for 16 h, and cells were washed and incubated for 4 h without TPCS2a. THP-1 cells were stained or not stained with Cresyl Violet (1 µM, 5 min) exposed to 405-nm light (10%, 1 s), and imaged. Galectin-3 accumulation on phagosomes during infection with different Mtb strains was determined by fixing cells in 4% PFA for 20 min at 1, 4 and 24 h post infection, and imaging 16 fields of view with 40× objective per well. Caspase-1 activity was detected in monocytes using FAM-FLICA Caspase-1 Assay kit according to the manufacturer’s instructions.
Immunofluorescence analysis of ALG-2 in primary macrophages
Primary human macrophages were isolated, differentiated and infected with Mtb auxotroph (Mtb H37Rv mc26206::EBFP2) as previously described. Cells were fixed on ice 2 h 15 min post infection in methanol–acetone solution (50% methanol and 50% acetone). Cells were immediately stored at −20 °C. The following day, the fixative was decanted, and cold PBS was added to the cells for 1 h at room temperature. Blocking was done in PBS with 20% human serum for 20 min. Cells were incubated with ALG-2 antibody (1:50 in PBS with 20% human serum) overnight at 4 °C, washed with PBS × 3, stained with secondary antibody Alexa Fluor 647 (1:500 in PBS with 20% human serum) for 1 h and finally washed in PBS × 3. Images were acquired with Zeiss LSM880 microscope, and fluorescent images were deconvolved using Huygens Professional v18.10 (Scientific Volume Imaging, The Netherlands, http://svi.nl).
FIB–SEM sample preparation and correlative imaging
For correlative imaging experiments, two growth substrates were used, with different optical microscopy and fixation approaches. In the first approach, THP1-ASC-GFP Gal-3-RFP cells were seeded and infected as above on aclar slides micropatterned by thermomoulding, using a silicon stamp produced by a photolithography workflow. Aclar substrates were placed in 24-well plates and imaged live using 10× objective as above. After 24 h, cells were fixed in 2.5% glutaraldehyde in 100 mM PIPES for 1 h, placed upside-down in 35-mm glass-bottom dishes and cells of interest were re-imaged using 63 × 1.2 W objective on a Leica SP8 confocal microscope. In the second approach, THP-1 cells were seeded and infected as above on micropatterned polymer coverslips (ibidi) mounted in 8-well sticky-Slides (ibidi). Samples were imaged using 40 × 1.3 oil objective on a Leica SP8 confocal microscope and fixed by adding 8% paraformaldehyde (PFA) and 0.2% GA in 200 mM PIPES directly into imaging media at a 1:1 ratio. After 20 min, fixation media was changed to fresh 4% PFA and 0.1% GA in 100 mM PIPES. Cells with interesting events during live microscopy were then re-imaged with a 40 × 1.2 Imm AutoCorr objective on a Zeiss LSM880 microscope using the Airyscan mode. After re-imaging, cells were placed in fresh fixative (2% PFA and 2.5% GA in 100 mM PIPES) and incubated at 4 °C overnight. After fixation, cells were postfixed and contrasted in 1.5% potassium ferrocyanide and 2% osmium tetroxide in 0.1 M cacodylate buffer for 4 h on ice, on a shaking platform. Cells were then dehydrated in 50% and 70% ethanol for 10 min per step, on a shaker. Further, cells were en bloc stained in 2% uranyl acetate in 75% ethanol for 1 h and 20 min at room temperature. Cells were further dehydrated in 90% and 100% ethanol (four steps) and embedded in Durcupan (Sigma-Aldrich) through three dilutions of ethanol and Durcupan (2:1, 1:1 and 1:2) for 1.5 h per step on a shaking platform. Samples were incubated on a rotator in 100% Durcupan overnight, changed to fresh Durcupan the next day and cured at 60 °C for a total of 3 days. Polymer growth substrates were removed, and samples were attached to SEM sample stubs with a drop of Durcupan before the last day of curing. Before FIB–SEM imaging, a layer of 40 nm platinum/palladium was deposited on the samples using a Cressington sputter coater model 208 HR. FIB–SEM imaging and tomography experiments were performed on a Helios G4 dual-beam FIB–SEM from ThermoFisher, with the software Auto Slice and View 4. Acceleration voltage was 2 kV or 3 kV for the electron beam, and immersion mode and the in-column mirror detector were used for image acquisition. Slice thickness was typically set to 20 nm or 25 nm. Initial alignments, scaling and simple adjustments (brightness/contrast) were done in Fiji, while 3D reconstructions were performed semi-manually in Avizo or Dragonfly.
Cathepsin B activity assay
THP-1 cells were differentiated in 24-well plates as above. One hour prior to lysis, inhibitors (K777 and Ca-074-Me) were added at concentrations indicated in the main text. Cells were lysed in 200 µL of lysis buffer (0.1% Triton X-100, 250 mM sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA and 0.5 mM Pefabloc SC, pH=7.5) on ice for 20 min108. In total, 50 µL of lysate was mixed with 50 µL of Cathepsin B reaction buffer (50 mM sodium acetate, 4 mM EDTA, 0.5 mM Pefabloc SC, 8 mM dithiothreitol (DTT) and 50 µM Z-RR-AMC, pH = 6.0), incubated at 30 °C for 5 min and fluorescence intensity was monitored every 30 s for 20 min (ex 355/em 460 nm, POLARstar Omega microplate reader).
Cell death pathways (Fig. 1f) were identified according to the following guidelines: pyroptotic cells were characterised as those forming a visible ASC speck followed by rapid influx of DRAQ7, while necrotic cells did not form ASC specks and generally followed a slower progression with, e.g., cessation of cell migration prior to a slower influx of DRAQ7. Apoptotic cells were identified by a characteristic membrane blebbing and no DRAQ7 influx.
CellProfiler was used to automatically segment and count live cells and ASC specks based on the ASC-GFP signal, dead cells based on the DRAQ7 signal and Mtb uptake based on Mtb-BFP signal overlapping with ASC-GFP signal in live cells. Bacterial burden per cell was also measured from live-cell time-lapse movies by mean Mtb-BFP intensity in infected cells immediately prior to ASC speck formation, and compared with cells surviving the duration of the experiment. The time point for the control cells was chosen to be the average time point for ASC-speck induction. Traces of DRAQ7, TMRE, Calbryte-590, PI or LysoView signal were generated by manually selecting ROIs around cells with or without ASC specks forming and measuring the mean intensity in the ROI over time. The data were aligned according to the time point of the first visible sign of the event under consideration and plotted as mean ± IQR.
In fixed cells images of Galectin-3 colocalisation with Mtb, the colocalisation was scored by a trained model in Ilastik and further analysed by CellProfiler. For analysis of ALG-2 recruitment events compared with Gal-3 recruitment events, only events where a complete overlap between increased Gal-3 signal and Mtb was followed by an overlap with an increased ALG-2 signal were scored as “ALG-2 after Gal-3” events. Data were plotted and statistically analysed using Python or GraphPad Prism, while images and figures were prepared using FIJI and Adobe Illustrator. TIRF/WF images of mNeonGreen-ALG-2 and Galectin-3 mScarlet were unmixed by linear unmixing due to substantial cross-excitation of mScarlet with 488-nm laser.
Detailed statistical analyses for individual experiments are listed in each figure legend. This includes the statistical test performed, the parameters shown and number of cells, replicates and independent experiments as appropriate. Data comparing the mean values of technical replicates of representative or independent experiments were analysed by two-sided unpaired Student’s t test (two groups) or one-way ANOVA (more groups). For one-way ANOVA, corrections for multiple comparisons were applied for comparisons with one control group (Dunnett’s) or all groups (Tukey’s). For comparisons of non-parametric data (fluorescent intensity or event timing), Mann–Whitney U test was used instead. GraphPad Prism 8.0 was used to perform all statistical analyses and determine p values, with p value <0.05 considered significant.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
The Python scripts for aligning intensity time-trace data and the CellProfiler and Ilastik pipelines used in this study are available from the corresponding author upon reasonable request.
World Health Organization. Global tuberculosis report 2019 (WHO, 2019).
Dorhoi, A. & Kaufmann, S. H. E. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin. Immunopathol. 38, 153–166 (2016).
Berghe, T. Vanden, Linkermann, A., Jouan-Lanhouet, S., Walczak, H. & Vandenabeele, P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 15, 135–147 (2014).
Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25, 486–541 (2018).
Rathinam, V. A. K. & Fitzgerald, K. A. Inflammasome complexes: emerging mechanisms and effector functions. Cell 165, 792–800 (2016).
Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10, 417–426 (2002).
Swanson, K. V., Deng, M. & Ting, J. P. Y. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 33, 477–489 (2019).
Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111–116 (2016).
Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153–158 (2016).
Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665 (2015).
He, W. et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 25, 1285–1298 (2015).
Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signaling. Nature 526, 666–671 (2015).
Evavold, C. L. et al. The pore-forming protein gasdermin D Regulates interleukin-1 secretion from living macrophages. Immunity 48, 35–44 (2018).
Mishra, B. B. et al. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell. Microbiol 12, 1046–1063 (2010).
Wong, K.-W. & Jacobs, W. R. Critical role for NLRP3 in necrotic death triggered by Mycobacterium tuberculosis. Cell. Microbiol. 13, 1371–1384 (2011).
Saiga, H. et al. Critical role of AIM2 in Mycobacterium tuberculosis infection. Int. Immunol. 24, 637–644 (2012).
Mayer-Barber, K. D. et al. Cutting edge: caspase-1 independent IL-1 production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184, 3326–3330 (2010).
Dorhoi, A. et al. Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis. Eur. J. Immunol. 42, 374–384 (2012).
Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514–518 (2009).
Bürckstümmer, T. et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10, 266–272 (2009).
Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J. & Alnemri, E. S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509–513 (2009).
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006).
Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847–856 (2008).
Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221–225 (2011).
Shimada, K. et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401–414 (2012).
Iyer, S. S. et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39, 311–323 (2013).
Muñoz-Planillo, R. et al. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142–1153 (2013).
Groß, C. J. et al. K+ efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity 45, 761–773 (2016).
Wolf, A. J. et al. Hexokinase is an innate immune receptor for the detection of bacterial peptidoglycan. Cell 166, 624–636 (2016).
Zhong, Z. et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature 560, 198–203 (2018).
Chen, J. & Chen, Z. J. PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation. Nature 564, 71–76 (2018).
Zhao, X. et al. Bcl-xL mediates RIPK3-dependent necrosis in M. tuberculosis-infected macrophages. Mucosal Immunol. 10, 1553–1568 (2017).
Pajuelo, D. et al. NAD+ depletion triggers macrophage necroptosis, a cell death pathway exploited by Mycobacterium tuberculosis. Cell Rep. 24, 429–440 (2018).
Hsu, T. et al. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc. Natl Acad. Sci. USA 100, 12420–12425 (2003).
van der Wel, N. et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129, 1287–1298 (2007).
Houben, D. et al. ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell. Microbiol. 14, 1287–1298 (2012).
Simeone, R. et al. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog. 8, e1002507 (2012).
Simeone, R., Majlessi, L., Enninga, J. & Brosch, R. Perspectives on mycobacterial vacuole-to-cytosol translocation: the importance of cytosolic access. Cell. Microbiol. 18, 1070–1077 (2016).
Wassermann, R. et al. Mycobacterium tuberculosis differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1. Cell Host Microbe 17, 799–810 (2015).
Abdallah, A. M. et al. Mycobacterial secretion systems ESX-1 and ESX-5 play distinct roles in host cell death and inflammasome activation. J. Immunol. 187, 4744–4753 (2011).
Amaral, E. P. et al. Lysosomal cathepsin release is required for NLRP3-inflammasome activation by Mycobacterium tuberculosis in infected macrophages. Front. Immunol. 9, 1427 (2018).
Mihalik, R., Imre, G., Petak, I., Szende, B. & Kopper, L. Cathepsin B-independent abrogation of cell death by CA-074-OMe upstream of lysosomal breakdown. Cell Death Differ. 11, 1357–1360 (2004).
Tschopp, J. & Schroder, K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10, 210–215 (2010).
Orlowski, G. M. et al. Multiple cathepsins promote Pro–IL-1β synthesis and NLRP3-mediated IL-1β activation. J. Immunol. 195, 1685–1697 (2015).
Christ, L., Raiborg, C., Wenzel, E. M., Campsteijn, C. & Stenmark, H. Cellular functions and molecular mechanisms of the ESCRT membrane-scission machinery. Trends Biochem. Sci. 42, 42–56 (2016).
Fernandes-Alnemri, T. et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14, 1590–1604 (2007).
Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248–255 (2015).
Lee, J., Repasy, T., Papavinasasundaram, K., Sassetti, C. & Kornfeld, H. Mycobacterium tuberculosis induces an atypical cell death mode to escape from infected macrophages. PLoS ONE 6, e18367 (2011).
Welin, A., Eklund, D., Stendahl, O. & Lerm, M. Human macrophages infected with a high burden of ESAT-6-expressing M. tuberculosis undergo caspase-1- and cathepsin B-independent necrosis. PLoS ONE 6, e20302 (2011).
Gurung, P. et al. Chronic TLR stimulation controls NLRP3 inflammasome activation through IL-10 mediated regulation of NLRP3 expression and caspase-8 activation. Sci. Rep. 5, 14488 (2015).
Beckwith, M. S. et al. Seeing a mycobacterium-infected cell in nanoscale 3D: correlative imaging by light microscopy and FIB/SEM tomography. PLoS ONE 10, e0134644 (2015).
Kuri, P. et al. Dynamics of in vivo ASC speck formation. J. Cell Biol. 216, 2891–2909 (2017).
Boucher, D. et al. Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity. J. Exp. Med. 215, 827–840 (2018).
Sani, M. et al. Direct visualization by Cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog. 6, e1000794 (2010).
Raffetseder, J., Iakobachvili, N., Loitto, V., Peters, P. J. & Lerm, M. Retention of EsxA in the capsule-like layer of Mycobacterium tuberculosis is associated with cytotoxicity and is counteracted by lung surfactant. Infect. Immun. 87, e00803–e00818 (2019).
Danilchanka, O. et al. An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity. Proc. Natl Acad. Sci. USA 111, 6750–6755 (2014).
Sun, J. et al. The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NAD. Nat. Struct. Mol. Biol. 22, 672–678 (2015).
Gurung, P., Lukens, J. R. & Kanneganti, T.-D. Mitochondria: diversity in the regulation of the NLRP3 inflammasome. Trends Mol. Med. 21, 193–201 (2015).
Gräb, J. et al. Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition. Nat. Commun. 10, 688 (2019).
Chen, M., Gan, H. & Remold, H. G. A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J. Immunol. 176, 3707–3716 (2006).
Scaduto, R. C. & Grotyohann, L. W. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys. J. 76, 469–477 (1999).
Paz, I. et al. Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell. Microbiol. 12, 530–544 (2010).
Lerner, T. R. et al. Lymphatic endothelial cells are a replicative niche for Mycobacterium tuberculosis. J. Clin. Invest. 126, 1093–1108 (2016).
Gutierrez, M. G. et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753–766 (2004).
Watson, R. O., Manzanillo, P. S. & Cox, J. S. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 150, 803–815 (2012).
Watson, R. O. et al. The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy. Cell Host Microbe 17, 811 (2015).
De Jonge, M. I. et al. ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J. Bacteriol. 189, 6028–6034 (2007).
Simeone, R. et al. Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo. PLoS Pathog. 11, e1004650 (2015).
De Leon, J. et al. Mycobacterium tuberculosis ESAT-6 exhibits a unique membrane-interacting activity that is not found in its ortholog from non-pathogenic Mycobacterium smegmatis. J. Biol. Chem. 287, 44184–44191 (2012).
Gong, T., Yang, Y., Jin, T., Jiang, W. & Zhou, R. Orchestration of NLRP3 inflammasome activation by ion fluxes. Trends Immunol. 39, 393–406 (2018).
Conrad, W. H. et al. Mycobacterial ESX-1 secretion system mediates host cell lysis through bacterium contact-dependent gross membrane disruptions. Proc. Natl Acad. Sci. USA 114, 1371–1376 (2017).
Divangahi, M. et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10, 899–906 (2009).
Scheffer, L. L. et al. Mechanism of Ca2+-triggered ESCRT assembly and regulation of cell membrane repair. Nat. Commun. 5, 5646 (2014).
Jimenez, A. J. et al. ESCRT machinery is required for plasma membrane repair. Science 343, 1247136 (2014).
Sønder, S. L. et al. Annexin A7 is required for ESCRT III-mediated plasma membrane repair. Sci. Rep. 9, 6726 (2019).
Mattheyses, A. L., Simon, S. M. & Rappoport, J. Z. Imaging with total internal reflection fluorescence microscopy for the cell biologist. J. Cell Sci. 123, 3621 (2010).
Hanson, P. I., Roth, R., Lin, Y. & Heuser, J. E. Plasma membrane deformation by circular arrays of ESCRT-III protein filaments. J. Cell Biol. 180, 389–402 (2008).
Konečný, P., Ehrlich, R., Gulumian, M. & Jacobs, M. Immunity to the dual threat of silica exposure and Mycobacterium tuberculosis. Front. Immunol. 9, 3069 (2019).
Berg, K. et al. Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization. Photochem. Photobiol. Sci. 10, 1637 (2011).
Lerner, T. R. et al. Mycobacterium tuberculosis replicates within necrotic human macrophages. J. Cell Biol. 216, 583–594 (2017).
Liu, T. et al. Single-cell imaging of caspase-1 dynamics reveals an all-or-none inflammasome signaling response. Cell Rep. 8, 974–982 (2014).
Netea, M. G. et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113, 2324–2335 (2009).
Okamoto, M. et al. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1β. J. Biol. Chem. 285, 6477–6488 (2010).
Hoss, F. et al. Alternative splicing regulates stochastic NLRP3 activity. Nat. Commun. 10, 3238 (2019).
Schneider, K. S. et al. The inflammasome drives GSDMD-independent secondary pyroptosis and IL-1 release in the absence of caspase-1 protease activity. Cell Rep. 21, 3846–3859 (2017).
Frank, D. & Vince, J. E. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 26, 99–114 (2019).
Taabazuing, C. Y., Okondo, M. C. & Bachovchin, D. A. Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages. Cell Chem. Biol. 24, 507–514 (2017).
Orning, P. et al. Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science 362, 1064–1069 (2018).
Antonopoulos, C. et al. Caspase-8 as an effector and regulator of NLRP3 inflammasome signaling. J. Biol. Chem. 290, 20167–20184 (2015).
Mahamed, D. et al. Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells. eLife 6, e22028 (2017).
Repasy, T. et al. Intracellular bacillary burden reflects a burst size for Mycobacterium tuberculosis in vivo. PLoS Pathog. 9, e1003190 (2013).
Mayer-Barber, K. D. & Yan, B. Clash of the cytokine titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses. Cell. Mol. Immunol. 14, 22–35 (2017).
Abate, E. et al. Polymorphisms in CARD8 and NLRP3 are associated with extrapulmonary TB and poor clinical outcome in active TB in Ethiopia. Sci. Rep. 9, 3126 (2019).
Gutierrez, K. D. et al. MLKL activation triggers NLRP3-mediated processing and release of IL-1β independently of gasdermin-D. J. Immunol. 198, 2156–2164 (2017).
Conos, S. A. et al. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc. Natl Acad. Sci. USA 114, E961–E969 (2017).
Kurenuma, T. et al. The RD1 locus in the Mycobacterium tuberculosis genome contributes to activation of caspase-1 via induction of potassium ion efflux in infected macrophages. Infect. Immun. 77, 3992–4001 (2009).
Mangan, M. S. J. et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat. Rev. Drug Discov. 17, 588–606 (2018).
López-Jiménez, A. T. et al. The ESCRT and autophagy machineries cooperate to repair ESX-1-dependent damage at the Mycobacterium-containing vacuole but have opposite impact on containing the infection. PLoS Pathog. 14, e1007501 (2018).
Mittal, E. et al. Mycobacterium tuberculosis type VII secretion system effectors differentially impact the ESCRT endomembrane damage response. mBio 9, e01765–18 (2018).
Rühl, S. et al. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science 362, 956–960 (2018).
Gong, Y. et al. ESCRT-III acts downstream of MLKL to regulate necroptotic cell death and its consequences. Cell 169, 286–300 (2017).
Gao, L.-Y. et al. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol. Microbiol. 53, 1677–1693 (2004).
Smith, J. et al. Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole. Infect. Immun. 76, 5478–5487 (2008).
Amaral, E. P. et al. A major role for ferroptosis in Mycobacterium tuberculosis-induced cell death and tissue necrosis. J. Exp. Med. 216, 556–570 (2019).
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S. & Bartenschlager, R. Host-directed therapies for bacterial and viral infections. Nat. Rev. Drug Discov. 17, 35–56 (2018).
Tiscornia, G., Singer, O. & Verma, I. M. Production and purification of lentiviral vectors. Nat. Protoc. 1, 241–245 (2006).
Brinkman, E. K., Chen, T., Amendola, M. & van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168–e168 (2014).
Jäättelä, M. & Nylandsted, J. Quantification of lysosomal membrane permeabilization by cytosolic cathepsin and β-N-Acetyl-glucosaminidase activity measurements. Cold Spring Harb. Protoc. 11, 1017–1023 (2015).
We thank Liv Ryan and Unni Nonstad for FACS of THP-1 cells, Katherine Fitzgerald and Egil Lien at UMass for reading and commenting on the paper and members of the mycobacteria-HIV research group at CEMIR for valuable discussions. The fluorescence microscopy work was performed at the Cellular and Molecular Imaging Core Facility (CMIC), NTNU. CMIC is funded by the Faculty of Medicine at NTNU and Central Norway Regional Health Authority. Funding sources: The Research Council of Norway for support to the Norwegian Micro- and Nano-Fabrication Facility (NorFab) project number 245963/F5 (M.S.B. and S.U.); the Centre of Excellence grant to CEMIR project number 223255 and FRIPRO project number 287696 (to T.H.F.). NTNU Enabling Technologies for PhD funding project number 81771297 (to T.H.F.). The National Institutes of Health (NIH) by the grant R01 AI121354 (to M.N.).
The authors declare no competing interests.
Peer review information Nature Communications thanks Jennifer Phillips, Robert Wilkinson, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer review reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Beckwith, K.S., Beckwith, M.S., Ullmann, S. et al. Plasma membrane damage causes NLRP3 activation and pyroptosis during Mycobacterium tuberculosis infection. Nat Commun 11, 2270 (2020). https://doi.org/10.1038/s41467-020-16143-6
Frontiers in Immunology (2020)
Cellular & Molecular Immunology (2020)
Immunological Reviews (2020)